Cytomegalovirus (CMV), like other herpesviruses, has the unique ability to establish latent
infection with subsequent reactivation during periods of stress and immunosuppression …

Human herpesvirus 5, better known as cytomegalovirus (CMV), infects 50–90% of the adult
population worldwide and is the most common opportunistic infection in allogeneic …

CMV infection is an important cause of morbidity and mortality among HSCT recipients.
Optimal strategies for prevention and management of CMV disease following …

Cytomegalovirus (CMV) is a member of the Herpesviridae family and is characterized by a
lifelong latency in the host (Russell et al., 2011). Clinical presentations of CMV infection are …

Cytomegalovirus (CMV) remains an important pathogen in hematopoietic stem cell
transplant (HCT) recipients in the current era of antiviral prophylaxis and preemptive …

Cytomegalovirus (CMV) remains a significant contributor to morbidity and death after
pediatric solid and stem cell transplantation. Decisions regarding prevention and treatment …

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality after
hematopoietic stem cell transplantation. Significant progress has been made in the …

Cytomegalovirus (CMV) infection is a significant source of morbidity and mortality in
allogeneic stem cell transplantation (SCT). We identified a cohort of 91 pediatric SCT …

The past 1–2 years have seen major developments in the area of CMV management in
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …

Cytomegalovirus (CMV) is an opportunistic virus, whereby recipients are most susceptible
following allogeneic hematopoietic stem cell transplantation (allo‑HSCT). With the …